Picture of Harvard Apparatus Regenerative Technology logo

HRGN — Harvard Apparatus Regenerative Technology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Biostage reports Q1 loss per share $0.14

May 11 (Reuters) - Biostage Inc  BSTG.O :  
    * Biostage reports 2017 first quarter financial results and 
provides business update 
    * Q1 loss per share $0.14 
    * Biostage Inc -  remains on track to file ind with fda for 
esophageal implant program in Q3 2017 
    * Biostage Inc -  believes it has sufficient cash on hand to 
fund operations through Q3 of 2017 
 
Source text for Eikon:  ID:nPn8s1Rjla  
Further company coverage:  BSTG.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Harvard Apparatus Regenerative Technology

See all news